Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 6 | 2020 | 159 | 1.520 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2020 | 1424 | 0.940 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 409 | 0.860 |
Why?
|
| Hypoglycemic Agents | 8 | 2017 | 181 | 0.770 |
Why?
|
| Chest Pain | 5 | 2020 | 207 | 0.730 |
Why?
|
| Risk Assessment | 8 | 2020 | 1431 | 0.730 |
Why?
|
| Psoas Muscles | 1 | 2019 | 19 | 0.670 |
Why?
|
| Mass Screening | 2 | 2020 | 263 | 0.640 |
Why?
|
| Sarcopenia | 1 | 2019 | 62 | 0.630 |
Why?
|
| Aged | 31 | 2020 | 10288 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 912 | 0.570 |
Why?
|
| Male | 39 | 2020 | 19091 | 0.550 |
Why?
|
| United States | 16 | 2020 | 3925 | 0.540 |
Why?
|
| Female | 36 | 2020 | 19859 | 0.510 |
Why?
|
| Humans | 48 | 2020 | 31836 | 0.500 |
Why?
|
| Middle Aged | 31 | 2020 | 11824 | 0.480 |
Why?
|
| Models, Statistical | 3 | 2014 | 173 | 0.480 |
Why?
|
| Adult | 23 | 2020 | 9327 | 0.480 |
Why?
|
| Proportional Hazards Models | 10 | 2019 | 756 | 0.470 |
Why?
|
| Online Systems | 1 | 2014 | 12 | 0.460 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 874 | 0.460 |
Why?
|
| Acute Coronary Syndrome | 3 | 2020 | 193 | 0.450 |
Why?
|
| Forecasting | 1 | 2014 | 144 | 0.450 |
Why?
|
| Diabetic Angiopathies | 3 | 2017 | 143 | 0.430 |
Why?
|
| Patient Readmission | 3 | 2019 | 113 | 0.430 |
Why?
|
| Mortality | 3 | 2020 | 124 | 0.430 |
Why?
|
| Cardiovascular Diseases | 3 | 2005 | 1122 | 0.420 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 216 | 0.390 |
Why?
|
| Cohort Studies | 8 | 2019 | 1824 | 0.370 |
Why?
|
| Point-of-Care Systems | 2 | 2017 | 44 | 0.370 |
Why?
|
| Neoplasms | 5 | 2013 | 692 | 0.360 |
Why?
|
| Hospitalization | 4 | 2020 | 463 | 0.360 |
Why?
|
| Risk Factors | 17 | 2019 | 3851 | 0.340 |
Why?
|
| Cholesterol | 3 | 2005 | 251 | 0.340 |
Why?
|
| C-Reactive Protein | 3 | 2005 | 239 | 0.340 |
Why?
|
| Health Care Costs | 1 | 2009 | 117 | 0.310 |
Why?
|
| Metformin | 4 | 2016 | 22 | 0.310 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 480 | 0.310 |
Why?
|
| Iron | 2 | 2005 | 115 | 0.310 |
Why?
|
| Medicare | 2 | 2019 | 206 | 0.300 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 159 | 0.300 |
Why?
|
| Transferrin | 2 | 2005 | 33 | 0.300 |
Why?
|
| Cholesterol, LDL | 2 | 2004 | 173 | 0.280 |
Why?
|
| Medical Records | 2 | 2003 | 76 | 0.270 |
Why?
|
| Patient Discharge | 3 | 2019 | 183 | 0.270 |
Why?
|
| Algorithms | 4 | 2020 | 495 | 0.260 |
Why?
|
| Odds Ratio | 6 | 2020 | 470 | 0.260 |
Why?
|
| Hypothyroidism | 1 | 2005 | 11 | 0.260 |
Why?
|
| Troponin | 3 | 2020 | 106 | 0.250 |
Why?
|
| Arginine | 1 | 2005 | 17 | 0.250 |
Why?
|
| Chlamydophila Infections | 1 | 2004 | 2 | 0.250 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2004 | 3 | 0.250 |
Why?
|
| Autoantibodies | 1 | 2005 | 49 | 0.250 |
Why?
|
| Macrolides | 1 | 2004 | 6 | 0.250 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 43 | 0.250 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 106 | 0.230 |
Why?
|
| Dementia | 2 | 2005 | 251 | 0.220 |
Why?
|
| Nomograms | 3 | 2014 | 32 | 0.220 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 37 | 0.220 |
Why?
|
| Resuscitation Orders | 1 | 2003 | 13 | 0.220 |
Why?
|
| Drug Combinations | 1 | 2003 | 93 | 0.220 |
Why?
|
| Religion and Medicine | 1 | 2003 | 19 | 0.220 |
Why?
|
| Young Adult | 5 | 2020 | 2603 | 0.220 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 11 | 0.220 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 16 | 0.210 |
Why?
|
| Physician's Role | 1 | 2003 | 40 | 0.210 |
Why?
|
| Enteral Nutrition | 1 | 2002 | 30 | 0.210 |
Why?
|
| Retrospective Studies | 11 | 2017 | 3488 | 0.210 |
Why?
|
| Sex Factors | 4 | 2020 | 662 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 300 | 0.200 |
Why?
|
| Time Factors | 5 | 2019 | 2146 | 0.200 |
Why?
|
| Comorbidity | 5 | 2017 | 566 | 0.200 |
Why?
|
| Logistic Models | 6 | 2020 | 777 | 0.200 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 470 | 0.190 |
Why?
|
| Prognosis | 4 | 2019 | 1498 | 0.190 |
Why?
|
| Age of Onset | 1 | 2020 | 93 | 0.180 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 16 | 0.170 |
Why?
|
| Holidays | 1 | 2019 | 3 | 0.170 |
Why?
|
| Models, Biological | 2 | 2012 | 391 | 0.170 |
Why?
|
| Body Mass Index | 2 | 2017 | 916 | 0.170 |
Why?
|
| Eggs | 1 | 2018 | 4 | 0.160 |
Why?
|
| Meat | 1 | 2018 | 15 | 0.160 |
Why?
|
| Heart Failure | 3 | 2017 | 620 | 0.160 |
Why?
|
| Internal Medicine | 1 | 2019 | 54 | 0.160 |
Why?
|
| Organ Size | 1 | 2019 | 208 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 251 | 0.160 |
Why?
|
| Survival Analysis | 4 | 2019 | 487 | 0.160 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 69 | 0.160 |
Why?
|
| Age Factors | 3 | 2019 | 1187 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 3988 | 0.150 |
Why?
|
| Glycemic Index | 1 | 2017 | 14 | 0.150 |
Why?
|
| Ethnic Groups | 1 | 2020 | 476 | 0.150 |
Why?
|
| Hip Fractures | 1 | 2017 | 30 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 168 | 0.150 |
Why?
|
| Feeding Behavior | 1 | 2018 | 161 | 0.150 |
Why?
|
| Pneumonia | 1 | 2017 | 66 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2017 | 75 | 0.150 |
Why?
|
| Nutrition Surveys | 4 | 2005 | 147 | 0.140 |
Why?
|
| Oximetry | 1 | 2016 | 31 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2017 | 177 | 0.140 |
Why?
|
| Catheterization, Peripheral | 1 | 2016 | 27 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 42 | 0.140 |
Why?
|
| Diet | 1 | 2018 | 385 | 0.130 |
Why?
|
| Risk | 4 | 2015 | 318 | 0.130 |
Why?
|
| Emergency Service, Hospital | 4 | 2020 | 471 | 0.130 |
Why?
|
| Sulfonylurea Compounds | 5 | 2015 | 7 | 0.130 |
Why?
|
| Oxygen | 1 | 2016 | 140 | 0.130 |
Why?
|
| Smoking | 4 | 2009 | 499 | 0.130 |
Why?
|
| Social Class | 1 | 2015 | 88 | 0.130 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 398 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 135 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 97 | 0.120 |
Why?
|
| Adolescent | 2 | 2020 | 3511 | 0.120 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 128 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2014 | 10 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 22 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 899 | 0.120 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 59 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 165 | 0.110 |
Why?
|
| Databases, Factual | 2 | 2012 | 349 | 0.110 |
Why?
|
| Decision Making | 1 | 2015 | 194 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2014 | 236 | 0.110 |
Why?
|
| Albuminuria | 1 | 2013 | 181 | 0.100 |
Why?
|
| Computational Biology | 1 | 2012 | 91 | 0.100 |
Why?
|
| Stroke | 1 | 2017 | 581 | 0.100 |
Why?
|
| Energy Intake | 2 | 2018 | 126 | 0.100 |
Why?
|
| North Carolina | 3 | 2020 | 1514 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2011 | 27 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1158 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2009 | 15 | 0.090 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 11 | 0.090 |
Why?
|
| Unemployment | 1 | 2009 | 4 | 0.090 |
Why?
|
| Incidence | 3 | 2013 | 1192 | 0.090 |
Why?
|
| Efficiency | 1 | 2009 | 18 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 21 | 0.090 |
Why?
|
| ROC Curve | 3 | 2017 | 167 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2020 | 2277 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1323 | 0.080 |
Why?
|
| Employment | 1 | 2009 | 48 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 72 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 50 | 0.080 |
Why?
|
| Health Surveys | 1 | 2009 | 196 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 85 | 0.080 |
Why?
|
| Software | 1 | 2009 | 127 | 0.080 |
Why?
|
| Thiazolidinediones | 3 | 2015 | 47 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2009 | 89 | 0.080 |
Why?
|
| Length of Stay | 1 | 2009 | 315 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2009 | 213 | 0.070 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 156 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2017 | 32 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2007 | 43 | 0.070 |
Why?
|
| Triglycerides | 2 | 2005 | 230 | 0.070 |
Why?
|
| African Americans | 2 | 2020 | 1428 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 771 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2008 | 895 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 144 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 2271 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 686 | 0.070 |
Why?
|
| Prevalence | 2 | 2019 | 979 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3294 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Thyroglobulin | 1 | 2005 | 2 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2005 | 4 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 43 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2005 | 8 | 0.060 |
Why?
|
| Thyroxine | 1 | 2005 | 16 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 24 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2005 | 19 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 81 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2020 | 632 | 0.060 |
Why?
|
| Mental Recall | 1 | 2005 | 51 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2005 | 148 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 268 | 0.060 |
Why?
|
| Ferritins | 1 | 2004 | 46 | 0.060 |
Why?
|
| Lipids | 1 | 2005 | 228 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 177 | 0.060 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2003 | 1 | 0.060 |
Why?
|
| Nutrition Disorders | 1 | 2002 | 12 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2002 | 8 | 0.050 |
Why?
|
| Registries | 2 | 2015 | 295 | 0.050 |
Why?
|
| Canada | 1 | 2002 | 56 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2002 | 17 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 251 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2002 | 52 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2003 | 147 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 504 | 0.050 |
Why?
|
| Glipizide | 2 | 2012 | 2 | 0.050 |
Why?
|
| Glyburide | 2 | 2012 | 4 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 327 | 0.050 |
Why?
|
| Acute Disease | 1 | 2020 | 252 | 0.040 |
Why?
|
| Exercise | 1 | 2005 | 663 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 764 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 589 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2018 | 57 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 518 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 97 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2019 | 221 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 51 | 0.040 |
Why?
|
| Partial Pressure | 1 | 2016 | 6 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 17 | 0.040 |
Why?
|
| Quality of Life | 1 | 2002 | 924 | 0.040 |
Why?
|
| Goals | 1 | 2016 | 36 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 162 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 84 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1169 | 0.030 |
Why?
|
| Radiculopathy | 1 | 2015 | 5 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 12 | 0.030 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 293 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 491 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 75 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2015 | 49 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 284 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2020 | 942 | 0.030 |
Why?
|
| Biguanides | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 58 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 49 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1527 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 884 | 0.030 |
Why?
|
| Propensity Score | 1 | 2012 | 39 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2015 | 398 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 161 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 353 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 221 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 91 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 323 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 956 | 0.020 |
Why?
|
| Ileostomy | 1 | 2009 | 8 | 0.020 |
Why?
|
| Child | 1 | 2016 | 2425 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 23 | 0.020 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2009 | 15 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2009 | 11 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 90 | 0.020 |
Why?
|
| Reoperation | 1 | 2009 | 226 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 593 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 208 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 100 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 456 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 369 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 191 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 14 | 0.020 |
Why?
|
| Survivors | 1 | 2009 | 159 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 82 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 515 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 760 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2007 | 537 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 195 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 206 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 32 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 607 | 0.010 |
Why?
|